Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3308594018 | Reslizumab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3308595017 | Reslizumab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 837871000172119 | reslizumab | fr | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| 837881000172116 | reslizumab | nl | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | Belgian module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Reslizumab (substance) | Is a | Respiratory system agent (substance) | true | Inferred relationship | Some | ||
| Reslizumab (substance) | Is a | Monoclonal antibody agent | false | Inferred relationship | Some | ||
| Reslizumab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Reslizumab (substance) | Is a | Substance with interleukin 5 receptor antagonist mechanism of action (substance) | true | Inferred relationship | Some | ||
| Reslizumab (substance) | Has disposition (attribute) | Interleukin 5 receptor antagonist | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing only reslizumab in parenteral dose form (medicinal product form) | Has active ingredient | True | Reslizumab (substance) | Inferred relationship | Some | 1 |
| Product containing reslizumab (medicinal product) | Has active ingredient | True | Reslizumab (substance) | Inferred relationship | Some | 1 |
| Reslizumab only product | Has active ingredient | True | Reslizumab (substance) | Inferred relationship | Some | 1 |
| Reslizumab-containing product in parenteral dose form | Has active ingredient | True | Reslizumab (substance) | Inferred relationship | Some | 1 |
Reference Sets
Belgian subset for AllergyIntolerance, causative agent, drug
FHIR